NEW YORK (GenomeWeb News) – Proteome Systems’ shareholders have agreed to change the name of the company to Tyrian Diagnostics in order to reflect its shift toward a biomarker-based diagnostics business, the company said today.
 
Tyrian Diagnostics said the renaming completes the moves the company has been making to focus on biomarkers.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.